Celldex Therapeutics Inc (CLDX)

Dec 20, 2024

What Analysts Are Saying About Celldex Therapeutics Stock - Benzinga

Dec 20, 2024

Dec 19, 2024

Celldex Therapeutics' (CLDX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 19, 2024

Dec 19, 2024

Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis - The Manila Times

Dec 19, 2024

Dec 19, 2024

Celldex Launches Pivotal Phase 2 Trial for Novel Atopic Dermatitis Treatment, Targeting 20% of US Population - StockTitan

Dec 19, 2024

Dec 17, 2024

State Street Corp Sells 173,932 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 17, 2024

Dec 16, 2024

Celldex Therapeutics' SWOT analysis: barzolvolimab drives stock potential By Investing.com - Investing.com Canada

Dec 16, 2024

Dec 16, 2024

Celldex Therapeutics' SWOT analysis: barzolvolimab drives stock potential - Investing.com

Dec 16, 2024

Dec 14, 2024

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 5.5%Here's Why - MarketBeat

Dec 14, 2024

Dec 11, 2024

BNP Paribas Financial Markets Boosts Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 11, 2024

Dec 09, 2024

XTX Topco Ltd Makes New $1.56 Million Investment in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 09, 2024

Dec 08, 2024

Wellington Management Group LLP Acquires 1,167,659 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 08, 2024

Dec 08, 2024

The Manufacturers Life Insurance Company Cuts Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 08, 2024

Dec 05, 2024

Readystate Asset Management LP Takes $6.10 Million Position in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Redmile Group LLC Cuts Stock Position in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Cinctive Capital Management LP Decreases Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 04, 2024

Dec 03, 2024

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock Position Decreased by Fmr LLC - MarketBeat

Dec 03, 2024

Dec 03, 2024

Analysts Set Celldex Therapeutics, Inc. (NASDAQ:CLDX) PT at $62.25 - MarketBeat

Dec 03, 2024

Dec 02, 2024

Prurigo Nodularis Pipeline Insights 2024: Therapies, Clinical - openPR

Dec 02, 2024

Dec 02, 2024

CBC acquires UCB’s neurology and allergy business in China - Pharmaceutical Technology

Dec 02, 2024

Dec 01, 2024

Bellevue Group AG Buys 100,000 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Dec 01, 2024

Nov 29, 2024

Intech Investment Management LLC Makes New $871,000 Investment in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Fisher Asset Management LLC Buys 253,808 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Nov 28, 2024

Nov 28, 2024

Algert Global LLC Sells 20,631 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Nov 28, 2024

Nov 27, 2024

Chronic Spontaneous Urticaria Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR

Nov 27, 2024

Nov 26, 2024

Celldex Therapeutics' SWOT analysis: barzolvolimab stock shows promise in urticaria treatment - Investing.com

Nov 26, 2024

Nov 26, 2024

Celldex Therapeutics' SWOT analysis: barzolvolimab stock shows promise in urticaria treatment By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 23, 2024

Celldex Therapeutics’ (CLDX) “Buy” Rating Reiterated at HC Wainwright - Defense World

Nov 23, 2024

Nov 22, 2024

HC Wainwright Has Positive Forecast for CLDX FY2025 Earnings - MarketBeat

Nov 22, 2024

Nov 22, 2024

Jennison Associates LLC Raises Stock Position in Celldex Therapeutics, Inc. (NASDAQ:CLDX) - MarketBeat

Nov 22, 2024

Nov 20, 2024

Insider Spends US$308k Buying More Shares In Celldex Therapeutics - Simply Wall St

Nov 20, 2024

Nov 20, 2024

Celldex Therapeutics (NASDAQ:CLDX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 20, 2024

Nov 20, 2024

Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases - The Manila Times

Nov 20, 2024

Nov 20, 2024

Celldex Launches Phase 1 Trial of Novel Dual-Action Inflammatory Disease Treatment | CLDX Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock - Benzinga

Nov 20, 2024

Nov 19, 2024

Celldex Therapeutics Reports Q3 2024 Progress and Financials - TipRanks

Nov 19, 2024

Nov 16, 2024

Celldex Therapeutics (NASDAQ:CLDX) Sets New 12-Month LowWhat's Next? - MarketBeat

Nov 16, 2024

Nov 15, 2024

Celldex stock touches 52-week low at $24.41 amid market shifts - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

Steven Cohen's Strategic Reduction in Celldex Therapeutics Holdi - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Eventide Asset Management's Strategic Acquisition in Celldex The - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Celldex Therapeutics' SWOT analysis: barzolvolimab stock potential in urticaria treatment - Investing.com India

Nov 14, 2024

Nov 13, 2024

Polar Capital Holdings Plc Reduces Stake in Celldex Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Insider Buying: Celldex Therapeutics Inc (CLDX) President & CEO Acquires Shares - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

FMR LLC's Strategic Reduction in Celldex Therapeutics Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Celldex Therapeutics (NASDAQ:CLDX) Trading 4.2% Higher Following Insider Buying Activity - Defense World

Nov 13, 2024

Nov 12, 2024

Insider Buying: Celldex Therapeutics, Inc. (NASDAQ:CLDX) CEO Buys 11,500 Shares of Stock - MarketBeat

Nov 12, 2024

Nov 11, 2024

Celldex Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Nov 11, 2024

Nov 11, 2024

Celldex (CLDX) to Present at Two Major Healthcare Investor Conferences in Q4 | CLDX Stock News - StockTitan

Nov 11, 2024